With the astounding success of some of the new personalized medicine therapies in treating incurable diseases, the emphasis on research and development of cell, gene and immunotherapies is growing momentum. Some of the more promising cures for cancer are now in late-stage development, with two expected to be FDA approved by the end of 2017.
On June 30, 2017, Peru's Ministry of Health (MINSA) issued a new regulation that will reinstate clinical studies for the pediatric population and native communities.
Solution delivers precious blood and blood products within stringent turn around times to help save lives.
Precise logistics planning for safest routings and contingency plans to reduce risk of delay and temperature excursion of life-saving medication.